Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3522-3531

  Suci, Peter A ^a   Tyler, Bonnie J ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE GLUCONATE; PROPIDIUM IODIDE;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL STRUCTURE; CONCENTRATION RESPONSE; DRUG PENETRATION; FUNGUS HYPHAE; HISTOGRAM; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; YEAST;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; BIOFILMS; CANDIDA ALBICANS; CHLORHEXIDINE; COLORING AGENTS; CULTURE MEDIA; CYTOPLASM; DISINFECTANTS; DRUG RESISTANCE, FUNGAL; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, FLUORESCENCE; PROPIDIUM; SPECTRUM ANALYSIS, RAMAN;

EID: 0036840579     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3522-3531.2002     Document Type: Article

References (46)

1. Baillie, G. S., and L. J. Douglas. 1998. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob. Agents Chemother. 42:2146-2149.
2. Baillie, G. S., and L. J. Douglas. 1999. Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 48:671-679.
3. Barrett-Bee, K., L. Newboult, and S. Edwards. 1994. The membrane destabilising action of the antibacterial agent chlorhexidine. FEMS Microbiol. Lett. 119:249-253.
4. Beggs, W. H. 1989. Development of phenotypic resistance to direct lethal miconazole action by Candida albicans entering stationary phase. Mycopathologia 108:201-206.
5. Bobichon, H., and P. Bouchet. 1987. Action of chlorhexidine on budding Candida albicans: scanning and transmission electron microscopic study. Mycopathologia 100:27-35.
6. Cannon, R. D., and D. Kerridge. 1988. Correlation between the sterol composition of membranes and morphology in Candida albicans. J. Med. Vet. Mycol. 26:57-65.
7. Chaffin, W. L., J. L. Lopez-Ribot, M. Casanova, D. Gozalbo, and J. P. Martinez. 1998. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62:130-180.
8. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
9. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908.
10. Dankert, J., A. H. Hogt, and J. Feijen. 1986. Biomedical polymers: bacterial adhesion, colonization, and infection. Crit. Rev. Biocompat. 2:219-301.
11. Doebbeling, B. N., G. L. Stanley, C. T. Sheetz, M. A. Pfaller, A. K. Houston, L. Annis, N. Li, and R. P. Wenzel. 1992. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N. Engl. J. Med. 327:88-93.
12. Dougherty, S. H. 1989. Pathobiology of infection in prosthetic devices. Rev. Infect. Dis. 10:1102-1117.
13. Fridkin, S. F., and W. R. Jarvis. 1996. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9:499-511.
14. Frolund, B., P. A. Suci, S. Langille, R. M. Weiner, and G. G. Geesey. 1996. Influence of protein conditioning films on binding of a bacterial polysaccharide adhesin from Hyphomonas MHS-3. Biofouling 10:17-30.
15. Gale, E. F. 1986. Nature and development of phenotypic resistance to amphotericin B in Candida albicans. Adv. Microb. Physiol. 27:277-320.
16. Gow, N. A. 1997. Germ tube growth of Candida albicans. Curr. Top. Med. Mycol. 8:43-55.
17. Green, L., B. Petersen, L. Steimel, P. Haeber, and W. Current. 1994. Rapid determination of antifungal activity by flow cytometry. J. Clin. Microbiol. 32:1088-1091.
18. Han, Y., R. P. Morrison, and J. E. Cutler. 1998. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 66:5771-5776.
19. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
20. Hawser, S. P., and L. J. Douglas. 1995. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39:2128-2131.
21. Hiom, S. J., J. R. Furr, A. D. Russell, and J. R. Dickinson. 1992. Effects of chlorhexidine diacetate on Candida albicans, C glabrata and Saccharomyces cerevisiae. J. Appl. Bacteriol. 72:335-340.
22. Hiom, S. J., J. R. Furr, A. D. Russell, and J. R. Dickinson. 1993. Effects of chlorhexidine diacetate and cetylpyridinium chloride on whole cells and protoplasts of Saccharomyces cerevisiae. Microbios 74:111-120.
23. Hugo, W. B., and A. R. Longworth. 1964. Some aspects of the mode of action of chlorhexidine. J. Pharm. Pharmacol. 16:655-662.
24. Hugo, W. B., and A. R. Longworth. 1966. The effect of chlorhexidine on the electrophoretic mobility, cytoplasmic constituents, dehydrogenase activity and cell walls of Escherichia coli and Staphylococcus aureus. J. Pharm. Pharmacol. 18:569-578.
25. Kuyyakanond, T., and L. B. Quesnel. 1992. The mechanism of action of chlorhexidine. FEMS Microbiol. Lett. 100:211-216.
26. Lam, J., R. Chan, K. Lam, and J. W. Costerton. 1980. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect. Immun. 28:546-556.
27. Lewis, K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:999-1007.
28. Leyes Borrajo, J. L., V. L. Garcia, C. G. Lopez, I. Rodriguez-Nunez, F. M. Garcia, T. M. Gallas. 2002. Efficacy of chlorhexidine mouthrinses with and without alcohol: a clinical study. J. Periodontol. 73:317-321.
29. Liljemarc, W., and F. Bloomquist. 1996. Human oral microbial ecology and dental caries and periodontal diseases. Crit. Rev. Oral. Biol. Med. 7:180-198.
30. Lo, H. J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
31. McDonnell, G., and A. D. Russell. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12:147-179.
32. Mishra, P., J. Bolard, and R. Prasad. 1992. Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast. Biochim. Biophys. Acta 1127:1-14.
33. Nikawa, H., T. Hamada, and T. Yamamoto. 1998. Denture plaque - past and recent concerns. J. Dent. 26:299-304.
34. Nugent, K. M., K. R. Couchot, and L. D. Gray. 1987. Effect of Candida morphology on amphotericin B susceptibility. Antimicrob. Agents Chemother. 31:335-336.
35. Odds, F. C. 1988. Candida and candidosis, p. 1-468. Bailliere Tindall, London, England.
36. Waller, M. A. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 22(Suppl. 2):S89-S94.
37. Ramani, R., A. Ramani, and S. J. Wong. 1997. Rapid flow cytometric susceptibility testing of Candida albicans. J. Clin. Microbiol. 35:2320-2324.
38. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887-892.
39. Sheppard, F. C., D. J. Mason, S. F. Bloomfield, and V. A. Gant. 1997. Flow cytometric analysis of chlorhexidine action. FEMS Microbiol. Lett. 154:283-288.
40. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
41. Suci, P. A., G. G. Geesey, and B. J. Tyler. 2001. Integration of Raman microscopy, differential interference contrast microscopy, and attenuated total reflection Fourier transform infrared spectroscopy to investigate chlorhexidine spatial and temporal distribution in Candida albicans biofilms. J. Microbiol. Methods 46:193-208.
42. Suci, P. A., K. J. Siedleki, R. J. Palmer, Jr., D. C. White, and G. G. Geesey. 1997. Combined light microscopy and attenuated total reflection Fourier transform spectroscopy for integration of biofilm structure, distribution, and chemistry at solid-liquid interfaces. Appl. Environ. Microbiol. 63:4600-4603.
43. Tas, J., and G. Westerneng. 1981. Fundamental aspects of the interaction of propidium diiodide with nuclei acids studied in a model system of polyacrylamide films. J. Histochem. Cytochem. 29:929-936.
44. Tiraboschi, I. N., J. E. Bennett, C. A. Kauffman, J. H. Rex, C. Girmenia, J. D. Sobel, and F. Menichetti. 2000. Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium. Med. Mycol. 38(Suppl. 1):199-204.
45. Treybal, R. E. 1980. Mass transfer operations, p. 35. McGraw-Hill Book Co., London, England.
46. Walters, T. H., J. R. Furr, and A. D. Russel. 1983. Antifungal action of chlorhexidine. Microbios 38:195-204.